Low-dose Methotrexate has Similar Outcomes to High-dose Methotrexate in Combination with Anti-TNF Therapy in Inflammatory Bowel Diseases

BACKGROUND AND AIMS: Methotrexate [MTX] is a well-known immunomodulator in the treatment of inflammatory bowel disease [IBD] and is often combined with biologic agents. The ideal MTX dose for combination therapy has not been determined. This study aimed to investigate the effect of varying doses of...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Crohns Colitis
Asıl Yazarlar: Borren, Nienke Z, Luther, Jay, Colizzo, Francis P, Garber, John G, Khalili, Hamed, Ananthakrishnan, Ashwin N
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2019
Konular:
Original Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6692531/
https://ncbi.nlm.nih.gov/pubmed/30888405
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ecco-jcc/jjz020
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller